|
A |
B |
C |
D |
E |
F |
G |
H |
I |
J |
K |
L |
M |
N |
O |
P |
Q |
R |
S |
T |
U |
V |
W |
X |
Y |
Z
Recent news on
Didanosine
Five Days Of LEVAQUIN(R) As Effective As 10 Days Of Ciprofloxacin ... - May 22, 2007 Medical News Today (press release),...metal cations such as iron, and multivitamin preparations with zinc, or Videx(R) (didanosine) chewable/buffered tablets or the pediatric powder for oral
Five Days of LEVAQUIN(R) as Effective as 10 Days of Ciprofloxacin ... - May 21, 2007 PR Newswire (press release),...and multivitamin preparations with zinc, or Videx(R)* (didanosine) chewable/buffered tablets or the pediatric powder for oral solution, should be taken
5 Days Of Levaquin As Effective As 10 Days Of Ciprofloxacin In ... - May 21, 2007 eMaxHealth.com,Antacids containing magnesium or aluminum, as well as sucralfate, metal cations such as iron, and multivitamin preparations with zinc, or Videx (didanosine)
Clinton Foundation announces new price cuts for tenofovir and ... - May 9, 2007 Aidsmap,...while another second-line nucleoside analogue, didanosine, falls from an average of $1096 in lower middle-income countries to $248 a year.
FDA Approves Oscient Pharmaceuticals' FACTIVE(R) Tablets for Five ... - May 2, 2007 PipelineReview.com (press release),...multivitamins containing metal cations, and didanosine. The safety and effectiveness of FACTIVE in children, adolescents (less than 18 years of age),
China and HIV — A Window of Opportunity - May 2, 2007 New England Journal of Medicine (subscription),Relying almost entirely on generic drugs produced in China, the country's first-line therapy regimens — zidovudine, didanosine, and nevirapine or zidovudine
Adverse effects of ARVs - Apr 1, 2007 ZimDaily,Didanosine. Nausea and vomiting are common. In above 6% of cases, pancreatitis (damage to pancreas, or rwatata in Shona); and damage to nerves of feet
d4T dose can be reduced without loss of effectiveness, meta ... - Apr 2, 2007 Aidsmap,A randomised, dose-finding study with didanosine plus stavudine versus didanosine alone in antiviral-naļve, HIV-infected Thai patients. AIDS 14:1375-1382,
Narrative Review: Antiretroviral Therapy to Prevent the Sexual ... - Apr 16, 2007 Annals of Internal Medicine3TC = lamivudine; ABC = abacavir; APV = amprenavir; ATV = atazanavir; d4T = stavudine; ddI = didanosine; DLV = delavirdine; EFV = efavirenz;
FDA Extends Marketing Exclusivity for LEVAQUIN(R - Mar 30, 2007 Drug Newswire (press release),...and multivitamin preparations with zinc, or Videx(R)* (didanosine) chewable/buffered tablets or the pediatric powder for oral solution, should be taken
Merck & Co., Inc. To Distribute ATRIPLAâ„¢ in Developing Countries - Feb 16, 2007 WebWire (press release),Coadministration of ATRIPLA and didanosine should be undertaken with caution. Patients receiving this combination should be monitored closely for
'AIDS Drug Prices to Die For' - AIDS Healthcare Foundation Targets ... - Feb 23, 2007 PR Newswire (press release),...and Reyataz (atazanavir) and Videx (didanosine or DDL), both of which can be key components of effective combined AIDS drug regimens or cocktails.
New Treatment Guidelines for Community-Acquired Pneumonia ... - Feb 22, 2007 PharmaLive.com (press release),...interactions include probenicid, sucralfate, antacids containing aluminum or magnesium, iron, multivitamins containing metal cations, and didanosine.
HIV patients may have to pop pills just once a day - Jan 5, 2007 Pune Newsline,These include emtricitabine (FTC) and atazanavir plus didanosine enteric coated (ddI-EC) for the trial participants. “These tablets are being given just
Company Announces Acquisition of Research and Development Programs ... - Dec 26, 2006 Drug Newswire (press release),...registration of important drugs for the treatment of HIV and Cancer, including paclitaxel (Taxol(R)), didanosine (Videx(R)), and stavudine (Zerit(R)).
Company Announces Acquisition of Research and Development Programs ... - Dec 22, 2006 Yahoo! News (press release)...and registration of important drugs for the treatment of HIV and Cancer, including paclitaxel (Taxol®), didanosine (Videx®), and stavudine (Zerit®).
Antiretroviral Therapy for HIV: New Data From HIV 8 in Glasgow - Dec 26, 2006 Medscape (subscription)Therefore, weight-based ribavirin dosing should now be recommended in the HIV setting, and didanosine coadministration should always be avoided.
Antiretroviral Therapy for HIV: New Data From HIV 8 in Glasgow - 26 Dec 2006 Medscape (subscription)Therefore, weight-based ribavirin dosing should now be recommended in the HIV setting, and didanosine coadministration should always be avoided.
South Africa: Scientists Warn State-Supplied Aids Drug Poses ... - Dec 6, 2006 AllAfrica.com,If patients develop severe side-effects or resistance, they switch to "second-line therapy", based on zidovudine (AZT), didanosine (ddI),
96-Week Data From Gilead’s Study 934 Comparing Viread ® and ... - Dec 15, 2006 Business Wire (press release),Coadministration of ATRIPLA and didanosine should be undertaken with caution. Patients receiving this combination should be monitored closely for
Company Announces Acquisition of Research and Development Programs ... - Dec 22, 2006 PR Newswire (press release),...registration of important drugs for the treatment of HIV and Cancer, including paclitaxel (Taxol(R)), didanosine (Videx(R)), and stavudine (Zerit(R)).
Company Announces Acquisition of Research and Development Programs ... - Dec 22, 2006 Yahoo! News (press release)...and registration of important drugs for the treatment of HIV and Cancer, including paclitaxel (Taxol®), didanosine (Videx®), and stavudine (Zerit®).
Triple nuke combination of AZT/3TC/tenofovir below current ... - Dec 17, 2006 Aidsmap,Despite reports emerging in 2003 that tenofovir/3TC in combination with abacavir (Ziagen) or ddI (didanosine, Videx/Videx EC) had a high rate of early
Breakthrough deal signed for paediatric HIV drugs - Dec 1, 2006 Pharma Times (subscription),The other ARVs for which the Clinton Foundation has negotiated price reductions include abacavir, didanosine, efavirenz and zidovudine.
President Clinton Announces Breakthroughs In HIV/AIDS Treatment ... - Nov 30, 2006 Medical News Today (press release),In addition to the three ARVs included in the pediatric FDC, the other ARVs for which CHAI has negotiated price reductions include abacavir, didanosine,
FDA Accepts as ``Complete Response'' Oscient Pharmaceuticals ... - Nov 28, 2006 PipelineReview.com (press release),...interactions include probenicid, sucralfate, antacids containing aluminum or magnesium, iron, multivitamins containing metal cations, and didanosine.
Aurobindo receives approval for Didanosine oral suspension Oct 10, 2006 Aurobindo takes pleasure to inform that the US FDA has granted tentative approval for Aurobindo’s Didanosine Oral Suspension (Pediatric Powder) 10 mg / ml. ... -Moneycontrol.com,
Aurobindo gets USFDA approval for Didanosine oral suspension Oct 10, 2006 Aurobindo Pharma (Q, N,C,F)* has received the USFDA approval for the company`s Didanosine oral suspension (pediatric powder) 10 mg/ml. ... -Myiris.com,
Second generic abacavir approved for PEPFAR Nov 7, 2006 Abacavir is likely to be used in developing countries as a second-line nucleoside analogue in combination with didanosine or tenofovir and one drug from ... -Aidsmap,
"Super Bug" Scares - Straight Facts About Antibiotic Resistance Nov 6, 2006 ...magnesium or aluminum, as well as sucralfate, metal cations such as iron, and multivitamin preparations with zinc, or Videx®* (didanosine) chewable/buffered ... -Medical News Today (press release),
Aurobindo gets FDA nod for AIDS drug Oct 11, 2006 Pharma Ltd has announced that the United Sates Food and Drug Administration (USFDA) has granted tentative approval for the company's Didanosine Oral Suspension ... -Moneycontrol.com,
Bristol-Myers Squibb, Gilead Sciences And Merck & Co. Submit ... Oct 10, 2006 Coadministration of ATRIPLA with didanosine should be undertaken with caution. Patients receiving this combination should be monitored ... -Medical News Today (press release),
New risk factors for severe liver toxicity identified in largest ... Nov 3, 2006 ...dual therapy comprising a one of two nucleoside reverse transcriptase inhibitors (NRTIs) - including AZT (zidovudine, Retrovir), ddI (didanosine, Videx), ddC ... -Aidsmap,
Aurobindo Gets FDA Nod for AIDS Drug Oct 12, 2006 12, 2006--Aurobindo Pharma Ltd has announced that the US FDA has granted tentative approval for the company's Didanosine Oral Suspension (paediatric powder) 10 ... -Therapeutics Daily (subscription) (press release),
Bristol-Myers Squibb, Gilead Sciences and Merck & Co. Submit ... Oct 8, 2006 ATRIPLA should bediscontinued in patients who develop tenofovir-associated adverse events.Coadministration of ATRIPLA with didanosine should be undertaken ... -Earthtimes.org
FACTIVE(R) Tablets Subject of Five Presentations at Third ... Oct 9, 2006 Drug-drug interactions include probenicid, sucralfate, antacids containing aluminum or magnesium, iron, multivitamins containing metal cations, and didanosine. ... -Business Wire (press release),
Findings from the United States, France and Canada in HIV/AIDS ... Oct 12, 2006 ..."The AIDS Clinical Trials Group (ACTG) study 384 randomized antiretroviral-naive individuals to receive didanosine/stavudine or zidovudine/lamivudine, plus ... -Therapeutics Daily (subscription) (press release),
AIDS drug prices to fall by 32% 24 Sep 2006 Drugs such as Nevirapine, Lamivudine, Didanosine, Indinavir would come at prices that are 7% to 32% less than supplied by private companies. ... -Financial Express
AIDS drug prices to fall 24 Sep 2006 As per initial estimates, RDPL would be able to make a 30-tablet/capsule pack of Didanosine 400 mg at Rs 1173, cheaper by over Rs 200 than Cipla's price. ... -Times of India
Oscient Pharmaceuticals Receives Approvable Letter from FDA for ... Sep 22, 2006 Drug-drug interactions include probenicid, sucralfate, antacids containing aluminum or magnesium, iron, multivitamins containing metal cations, and didanosine. ... -PharmaLive.com
Drug Combo Protects Arteries of HIV Patients Sep 8, 2006 ...used alone. The mice received a common protease inhibitor called ritonavir and one of two NRTIs -- either d4T or didanosine. The ... -Forbes
Stavudine, didanosine and AZT pose diabetes risk in D:A:D study - Nov 20, 2006 Aidsmap,The other two nucleosides associated with diabetes were ddI (didanosine, Videx) and AZT (zidovudine, used most frequently in Combivir) though they carried
South Africa: Scientists Warn State-Supplied Aids Drug Poses ... - Dec 6, 2006 AllAfrica.com,If patients develop severe side-effects or resistance, they switch to "second-line therapy", based on zidovudine (AZT), didanosine (ddI),
Breakthrough deal signed for paediatric HIV drugs - Dec 1, 2006 Pharma Times (subscription),The other ARVs for which the Clinton Foundation has negotiated price reductions include abacavir, didanosine, efavirenz and zidovudine.
President Clinton Announces Breakthroughs In HIV/AIDS Treatment ... - Nov 30, 2006 Medical News Today (press release),In addition to the three ARVs included in the pediatric FDC, the other ARVs for which CHAI has negotiated price reductions include abacavir, didanosine,
FDA Accepts as ``Complete Response'' Oscient Pharmaceuticals ... - Nov 28, 2006 PipelineReview.com (press release),...interactions include probenicid, sucralfate, antacids containing aluminum or magnesium, iron, multivitamins containing metal cations, and didanosine.
Tenofovir kidney toxicity: real, but uncommon and usually reversible - Nov 21, 2006 Aidsmap,Renal safety profile of tenofovir plus didanosine containing regimens. Results from the DIDITEN cohort. Eighth Congress on Drug Therapy in HIV Infection,
Van klinische proef van Gilead op 16de internationale AIDS ... Aug 14, 2006 Coadministration of ATRIPLA and didanosine should be undertaken with caution. Patients receiving this combination should be monitored ... -Netherlands Corporate News (persbericht)
Micronutrient supplement increases CD4 cell counts in patients on ... Aug 24, 2006 All of the participants were taking antiretroviral therapy containing d4T (stavudine, Zerit) or ddI (didanosine, Videx / VidexEC), and had symptoms of ... -Aidsmap
Barr Reports GAAP Earnings of $3.12 Per Share for Fiscal 2006 and ... Aug 15, 2006 ..."Increased generic sales were driven by Desmopressin and Didanosine, and continued strength in our oral contraceptive portfolio. ... -Finanzen.net
Brain problems and peripheral neuropathy under-diagnosed in Asia ... Aug 14, 2006 ...so-called “d� drugs from the nucleoside analogue (NRTI) class of anti-HIV drugs, with 37% taking either d4T (stavudine, Zerit) or ddI (didanosine, Videx). ... -Aidsmap
IAC: Micronutrients Improve Immune Function In HIV Aug 15, 2006 To be eligible for the study, patients also had to be taking either Videx (didanosine) or Zerit (stavudine) and have had persistent peripheral neuropathy. ... -MedPage Today
Drop d4T from first-line therapy, WHO advises low-income countries ... Aug 8, 2006 It should be combined with didanosine (ddI) and another nucleoside not used in first-line treatment, such as tenofovir or abacavir. ... -Aidsmap
Roche to Discontinue Hivid Jul 28, 2006 ...and specific recommendations within treatment guidelines state that Hivid should not be administered with the HIV medications didanosine, lamivudine, stavudine ... -Facts and Comparisons
Primary Mania Versus HIV-Related Secondary Mania in Uganda Jul 28, 2006 Br J Psychiatry 1988; 152:839–842[Abstract]. Brouillette MJ, Chouinard G, Lalonde R: Didanosine-induced mania in HIV infection (letter). ... -Am J Psychiatry (subscription)
Aurobindo receives US FDA approval for Didanosine (chewable) ... Jul 12, 2006 Aurobindo Pharma is proud to announce that the US FDA has granted tentative approval for Didanosine Tablets (Chewable)of strengths 100mg, 150mg & 200mg. ... -Moneycontrol.com
Aurobindo gets USFDA approval for Didanosine tablets Jul 12, 2006 Aurobindo Pharma (Q, N,C,F)* has received USFDA approval for Didanosine Tablets (Chewable) of strengths 100mg, 150mg & 200mg. This ... -Myiris.com
Aurobindo Gets USFDA Approval for Didanosine Chewable Tablets Jul 12, 2006 Aurobindo Pharma Ltd today said it has received tentative approval by USFDA for its anti-HIV drug, Didanosine chewable tablets of 100mg, 150mg and 200mg ... -MedIndia
FDA Approves ATRIPLA(TM), the First Once-Daily Single Tablet ... Jul 20, 2006 Coadministration of ATRIPLA and didanosine should be undertaken with caution. Patients receiving this combination should be monitored ... -dBusinessNews Newark
USFDA approval for Aurobindo's anti-HIV drug Jul 12, 2006 Aurobindo Pharma Ltd has received USFDA's tentaive approval for its anti-HIV drug, Didanosine chewable tablets of 100mg, 150mg and 200mg strengths. ... -Andhra Cafe
Aurobindo Pharma Receives Tentative FDA Approval To Produce ... Jul 13, 2006 ...has granted tentative approval to Indian drug manufacturer Aurobindo Pharma to produce a chewable tablet form of the antiretroviral drug didanosine, Iris.com ... -Kaiser network.org
Fatty liver prevalence high with HIV/HCV coinfection: 'use ddI and ... Jun 30, 2006 Individuals coinfected with HIV and hepatitis C virus (HCV) should use ddI (didanosine, Videx/Videx EC) and d4T (stavudine, Zerit) with caution, according to ... -Aidsmap
Aurobindo receives US FDA approval for Stavudine capsules Jun 30, 2006 Stavudine is an antiviral agent of the nucleoside analog class, which includes zidovudine (AZT), didanosine (ddI) and zalcitabine (ddC). The international. ... -Moneycontrol.com
15th HIV Resistance Workshop: does low-level resistance matter? Jul 6, 2006 Previous studies have alluded to the evolution of K65R mutation associated with tenofovir (TDF) with prior ABC or didanosine (ddI) use and emergence of the L74V ... -Aidsmap
Oscient Pharmaceuticals Announces Meeting Date for FDA Advisory ... Jun 28, 2006 Drug-drug interactions include probenicid, sucralfate, antacids containing aluminum or magnesium, iron, multivitamins containing metal cations, and didanosine. ... -Business Wire
Bristol-Myers Squibb and Gilead Sciences Submit New Drug ... Apr 27, 2006 Drug interactions have been observed when didanosine, atazanavir, or lopinavir/ritonavir are co-administered with Viread, a component of Truvada, and dose ... - International News Service
Long-term study plays down risk of brain problems in HIV-positive ... Apr 26, 2006 Treatment mainly consisted of monotherapy with AZT (zidovudine, Retrovir), ddI (didanosine, Videx) or ddC (zalcitabine, Hivid) although twelve patients had ... - Aidsmap
Next generation NRTI, DFC (formerly Reverset) discontinued to due ... 11 Apr 2006 Study 203 had found that a combination of DFC with ddI (didanosine, Videx/Videx EC led to a 50% incidence rate of grade 4 hyperlipasaemia, with seven of the 14 ... - Aidsmap
Oscient Pharmaceuticals' FACTIVE Tablets Subject of Poster ... Apr 4, 2006 Drug-drug interactions include probenicid, sucralfate, antacids containing aluminum or magnesium, iron, multivitamins containing metal cations, and didanosine. ... - International News Service
Tenofovir DF Remains Safe After 4 Years in the Treatment of HIV ... Apr 5, 2006 ...toxicity observed in the placebo-controlled trials -- which was proposed as a major advantage over several older NRTIs, such as didanosine and stavudine ... - DG News
HIV/AIDS: Designer Medicines To The Rescue Apr 4, 2006 ...conducted several clinical trials in partnership with industry to test four other nucleoside RT inhibitors: zalcitabine (ddC), didanosine (ddI), stavudine (D4T ... - Nigeria Daily Independent
Aurobindo Pharma granted licence by BMS Mar 17, 2006 Ltd today said that Bristol Myers Squibb (BMS) Company has granted licence to the company to market its antiretrovirals (ARV) Stavudine and Didanosine in 49 ... - Hindu
Bristol-Myers grants ARV license for two drugs to Aurobindo Pharma Mar 17, 2006 Aurobindo Pharma Ltd has been given the license to market Stavudine and Didanosine, two important anti retro virals by Bristol-Myers Squibb Company. ... - domain-B
Aurobindo gets mktg license by BMS for 2 ARV drugs Mar 17, 2006 Aurobindo Pharma Ltd said on Friday announced that the Company has been given the license to market Stavudine & Didanosine, two important Antiretrovirals by ... - India Infoline.com
Rare resistance mutation, K65N, means that multiple NRTIs don't ... Mar 26, 2006 Et al. A rare reverse transcriptase mutation, K65N, confers reduced susceptibility to tenofovir, lamivudine and didanosine. AIDS 20: 787 – 789, 2006. - Aidsmap
US FDA Grants Traditional Approval for Gilead's Once-Daily HIV ... Mar 8, 2006 Drug interactions have been observed when didanosine, atazanavir, or lopinavir/ritonavir are co-administered with Viread, a component of Truvada, and dose ... - DG News
Aurobindo Pharma granted licence for ARV products Mar 17, 2006 Ltd on Friday said that Bristol Myers Squibb Company has granted licence to the company to market its anti-retrovirals (ARV) Stavudine and Didanosine in 49 ... - Hindu Business Line
Aurobindo to sell BMS' anti-AIDS drugs Mar 17, 2006 ...(BMS) to market two anti-AIDS drugs in 49 countries, the Indian company said on Friday. The licences are for Stavudine and Didanosine, Aurobindo said. ... - Reuters India
Aurobindo to sell Bristol AIDS drugs Mar 17, 2006 ...anti-AIDS drugs in 49 countries. The licences are for Stavudine and Didanosine, Aurobindo said. The licence allows the company to ... - Business Standard
Fringe wins for pharma, but cos seek stronger dose Feb 28, 2006 Budget. Some of these drugs are cisplatin, stavudine, danazol and didanosine. However, the industry sees these as minor concessions. ... - Economic Times,
Simplified treatment regimens show promise in HIV-infected ... Feb 6, 2006 They treated the patients with a once-daily regimen of three anti-HIV drugs comprising ddI (didanosine, Videx / Videx EC), FTC (emtricitabine, Emtriva) and ... - Aidsmap,
Barr Reports Second Quarter Fiscal 2006 GAAP Earnings of $0.88 Per ... Feb 7, 2006 ...increase is primarily related to strong sales of the Company's Desmopressin product that was launched in July 2005 and sales of its Didanosine product that was ... - MSN Money
CROI: Tenofovir and kidney toxicity - low rates seen, but some ... Feb 9, 2006 Abstract #778. Crane H Didanosine and lower baseline body weight are associated with declining renal function among patients receiving tenofovir. ... - Aidsmap,
CROI: AZT, 3TC and FTC achieve good concentrations in the female ... Feb 17, 2006 The women were treated with antiretroviral regimens that included 3TC, AZT, abacavir (Ziagen), ddI (didanosine, Videx), d4T (stavudine, Zerit), efavirenz ... - Aidsmap,
This site is for informational purposes only--it does not offer medical advice or sell health products. If you need assistance, contact your physician or healthcare professional
|